Scientist I, Analytical Development jobs in United States
cer-icon
Apply on Employer Site
company-logo

Insmed Incorporated · 1 hour ago

Scientist I, Analytical Development

Insmed Incorporated is a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases. They are seeking a Scientist I on the Analytical Development team to develop and qualify assays for AAV gene therapy products and collaborate with various teams to ensure the timely execution of testing and reporting.

BiotechnologyMedicalPharmaceutical
check
Growth Opportunities
check
H1B Sponsor Likelynote

Responsibilities

Collaborate with QC to author and execute method transfer protocols and reports
Collaborate with research, analytical and process development teams to determine critical quality attributes (CQAs), monitor process and method performance, and troubleshoot
Develop and own timelines, protocols and reports for assay transfers, qualifications / validations
Ensure the timely execution of all routine non-GMP testing, data review, and preparation of summary reports
Maintain AD laboratory, track materials and reagents, and ensure all the equipment is maintained
Coordinate with CDMOs / CTLs to manage shipping, testing and reporting of outsourced analyses

Qualification

Cell-based potency assaysMolecular biology assaysChemical/biochemical assaysMethod developmentImmunoassaysProtein chemistry assaysFDA-regulated environmentLaboratory management softwareJMP statistical softwareOrganizational skillsCommunication skills

Required

BS degree in a relevant discipline along with 4+ years of relevant industry experience or a Master's degree in relevant discipline with 2+ years of relevant industry experience
Broad knowledge and expertise in cell-based potency assays, molecular biology assays, and chemical/biochemical assays as applied to AAV gene therapy products
Experience in pharmaceutical industry in an analytical development lab, ideally covering the analytical method and testing lifecycle from development through phase appropriate qualification
Experience in developing methods with particular emphasis on immunoassays and protein chemistry assays
Experience in an FDA-regulated environment with a focus on high throughput workflows
Excellent organizational and communication skills

Preferred

Experience with laboratory management software (ELN, Smartsheet, LIMS, etc.) a plus
Experience with JMP statistical software a plus

Benefits

Comprehensive medical, dental, and vision coverage and mental health support, annual wellbeing reimbursement, and access to our Employee Assistance Program (EAP)
Generous paid time off policies, fertility and family-forming benefits, caregiver support, and flexible work schedules with purposeful in-person collaboration
401(k) plan with a competitive company match, annual equity awards, and participation in our Employee Stock Purchase Plan (ESPP), and company-paid life and disability insurance
Company Learning Institute providing access to LinkedIn Learning, skill building workshops, leadership programs, mentorship connections, and networking opportunities
Employee resource groups, service and recognition programs, and meaningful opportunities to connect, volunteer, and give back

Company

Insmed Incorporated

twittertwittertwitter
company-logo
Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases.

H1B Sponsorship

Insmed Incorporated has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (20)
2024 (6)
2023 (14)
2022 (8)
2021 (1)
2020 (5)

Funding

Current Stage
Public Company
Total Funding
$4.56B
Key Investors
CureDuchenne Ventures
2025-06-11Post Ipo Equity· $750M
2024-05-30Post Ipo Equity· $650M
2023-05-08Post Ipo Equity· $0.5M

Leadership Team

leader-logo
Will Lewis
Chairman and Chief Executive officer
linkedin
leader-logo
Walter R. Perkins
Chief Technology Officer
linkedin
Company data provided by crunchbase